1211.HK vs. PFE
Compare and contrast key facts about BYD Co Ltd-H (1211.HK) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: 1211.HK or PFE.
Key characteristics
1211.HK | PFE | |
---|---|---|
YTD Return | 0.56% | -4.17% |
1Y Return | -6.53% | -26.83% |
3Y Return (Ann) | 10.89% | -7.49% |
5Y Return (Ann) | 33.33% | -3.40% |
10Y Return (Ann) | 18.60% | 2.99% |
Sharpe Ratio | -0.07 | -1.10 |
Daily Std Dev | 33.73% | 24.59% |
Max Drawdown | -87.08% | -69.72% |
Current Drawdown | -34.62% | -51.38% |
Fundamentals
1211.HK | PFE | |
---|---|---|
Market Cap | HK$663.66B | $143.83B |
EPS | HK$10.32 | $0.37 |
PE Ratio | 19.09 | 68.65 |
PEG Ratio | 0.81 | 0.26 |
Revenue (TTM) | HK$602.32B | $58.50B |
Gross Profit (TTM) | HK$71.41B | $66.23B |
EBITDA (TTM) | HK$74.33B | $11.52B |
Correlation
The correlation between 1211.HK and PFE is 0.04, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
1211.HK vs. PFE - Performance Comparison
In the year-to-date period, 1211.HK achieves a 0.56% return, which is significantly higher than PFE's -4.17% return. Over the past 10 years, 1211.HK has outperformed PFE with an annualized return of 18.60%, while PFE has yielded a comparatively lower 2.99% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
1211.HK vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BYD Co Ltd-H (1211.HK) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
1211.HK vs. PFE - Dividend Comparison
1211.HK's dividend yield for the trailing twelve months is around 0.58%, less than PFE's 6.07% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
BYD Co Ltd-H | 0.58% | 0.59% | 0.06% | 0.07% | 0.03% | 0.60% | 0.35% | 0.30% | 1.03% | 0.00% | 0.21% | 0.00% |
Pfizer Inc. | 6.07% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.47% | 3.34% | 3.14% |
Drawdowns
1211.HK vs. PFE - Drawdown Comparison
The maximum 1211.HK drawdown since its inception was -87.08%, which is greater than PFE's maximum drawdown of -69.72%. Use the drawdown chart below to compare losses from any high point for 1211.HK and PFE. For additional features, visit the drawdowns tool.
Volatility
1211.HK vs. PFE - Volatility Comparison
The current volatility for BYD Co Ltd-H (1211.HK) is 7.64%, while Pfizer Inc. (PFE) has a volatility of 8.76%. This indicates that 1211.HK experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
1211.HK vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between BYD Co Ltd-H and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities